These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22045383)

  • 21. Thioamycolamides A-E, Sulfur-Containing Cycliclipopeptides Produced by the Rare Actinomycete
    Pan C; Kuranaga T; Liu C; Lu S; Shinzato N; Kakeya H
    Org Lett; 2020 Apr; 22(8):3014-3017. PubMed ID: 32239955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, Synthesis, and Conformation-Activity Study of Unnatural Bridged Bicyclic Depsipeptides as Highly Potent Hypoxia Inducible Factor-1 Inhibitors and Antitumor Agents.
    Koike K; Nagano M; Ebihara M; Hirayama T; Tsuji M; Suga H; Nagasawa H
    J Med Chem; 2020 Apr; 63(8):4022-4046. PubMed ID: 32202785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
    Shi M; Guo XT; Shu MG; Chen FL; Li LW
    Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disulfide-rich macrocyclic peptides as templates in drug design.
    Northfield SE; Wang CK; Schroeder CI; Durek T; Kan MW; Swedberg JE; Craik DJ
    Eur J Med Chem; 2014 Apr; 77():248-57. PubMed ID: 24650712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide based macrocycles: selective histone deacetylase inhibitors with antiproliferative activity.
    Rajak H; Singh A; Dewangan PK; Patel V; Jain DK; Tiwari SK; Veerasamy R; Sharma PC
    Curr Med Chem; 2013; 20(14):1887-903. PubMed ID: 23409715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents.
    Jiang J; Sun B; Wang YY; Cui M; Zhang L; Cui CZ; Wang YF; Liu XG; Lou HX
    Bioorg Med Chem; 2012 Apr; 20(7):2382-91. PubMed ID: 22365913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer therapeutic agents targeting hypoxia-inducible factor-1.
    Wang R; Zhou S; Li S
    Curr Med Chem; 2011; 18(21):3168-89. PubMed ID: 21671859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
    Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
    Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bulky side chain of antillatoxin is important for potent toxicity: rational design of photoresponsive cytotoxins based on SAR studies.
    Okura K; Matsuoka S; Inoue M
    Chem Commun (Camb); 2013 Sep; 49(73):8024-6. PubMed ID: 23903352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformationally based design of macrocycles as antitumor agents.
    Singh EK; Sellers RP; Alexander LD; McAlpine SR
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):544-52. PubMed ID: 18600570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antiproliferative activity of new tonantzitlolone-derived diterpene derivatives.
    Busch T; Dräger G; Kunst E; Benson H; Sasse F; Siems K; Kirschning A
    Org Biomol Chem; 2016 Oct; 14(38):9040-5. PubMed ID: 27604289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, Synthesis and Biological Evaluation of a Structurally Simplified Syringolin A Analogues.
    Chiba T; Kitahata S; Matsuda A; Ichikawa S
    Chem Pharm Bull (Tokyo); 2016; 64(7):811-6. PubMed ID: 27373636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads.
    Donnell AF; Zhang Y; Stang EM; Wei DD; Tebben AJ; Perez HL; Schroeder GM; Pan C; Rao C; Borzilleri RM; Vite GD; Gangwar S
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5267-5271. PubMed ID: 29102228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, structure and hypoxic cytotoxicity of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
    Jiang F; Weng Q; Sheng R; Xia Q; He Q; Yang B; Hu Y
    Arch Pharm (Weinheim); 2007 May; 340(5):258-63. PubMed ID: 17464965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coassembly of hypoxia-sensitive macrocyclic amphiphiles and extracellular vesicles for targeted kidney injury imaging and therapy.
    Cheng YQ; Yue YX; Cao HM; Geng WC; Wang LX; Hu XY; Li HB; Bian Q; Kong XL; Liu JF; Kong DL; Guo DS; Wang YB
    J Nanobiotechnology; 2021 Dec; 19(1):451. PubMed ID: 34961540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rakicidin A: a hypoxia-selective cytotoxin.
    Yamazaki Y; Kunimoto S; Ikeda D
    Biol Pharm Bull; 2007 Feb; 30(2):261-5. PubMed ID: 17268062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in macrocyclic peptide-based antibiotics.
    Luther A; Bisang C; Obrecht D
    Bioorg Med Chem; 2018 Jun; 26(10):2850-2858. PubMed ID: 28886999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical applications of macrocyclic polyamines.
    Liang F; Wan S; Li Z; Xiong X; Yang L; Zhou X; Wu C
    Curr Med Chem; 2006; 13(6):711-27. PubMed ID: 16529561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic peptide facial amphiphile preprogrammed to self-assemble into bioactive peptide capsules.
    Chung EK; Lee E; Lim YB; Lee M
    Chemistry; 2010 May; 16(18):5305-9. PubMed ID: 20373308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.